Kathy Alcid
Optometry · San Leandro
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 3
- 1 carrier
- Office
- 1
- Since medical school
- 11 years
- University of California - School of Optometry, 2015
Offices
1 location · Bay Area Ophthalmic Medical Corporation · 3 clinicians in this group
Looking this up.
Plans that list them
3 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Kathy Alcid’s office at (510) 614-1515 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence A15281 · Cancelled
Licence status: Cancelled · since 1953 · University of Southern California Keck School of Medicine.
License has been voluntarily canceled, or the license has been expired for at least five years and has not been renewed. No practice is permitted.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$19,608
Medicare paid this office $19,608 for 158 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Established patient complete exam of visual system | 54 | $6,485 | $114 |
| Return visit (30+ min) | 44 | $4,386 | $95 |
| Short return visit (20+ min) | 45 | $3,214 | $71 |
| Established patient problem focused exam of visual system | 18 | $1,656 | $79 |
| Imaging of retina | 40 | $1,385 | $32 |
Who their Medicare patients are
158 Original Medicare patients in 2024. Average age 75 · Under 65 7% · 85 and older 17% · Women 70% · Also on Medicaid 30% · Health risk score 1.11. Above the middle of the specialty; the typical optometry clinician is at 0.97.
Conditions among them: High blood pressure 75% · Diabetes 28% · Chronic kidney disease 28% · Heart failure 20% · Coronary heart disease 17% · Cancer 17% · Depression 14% · Atrial fibrillation 13% · COPD 9% · Stroke 8%.
The office billed $65,411, Medicare allowed $29,315 and paid $19,608; for 254 services of 16 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 158 | 254 | 75 | 1.11 | $65,411 | $19,608 |
| 2023 | 127 | 236 | 75 | 1.07 | $32,609 | $17,284 |
| 2022 | 151 | 291 | 74 | 1.09 | $38,985 | $20,437 |
| 2021 | 151 | 311 | 75 | 1.01 | $43,522 | $24,818 |
| 2020 | 146 | 258 | 73 | 1.32 | $33,873 | $19,331 |
| 2019 | 184 | 358 | 73 | 1.07 | $43,171 | $25,758 |
| 2018 | 187 | 347 | 74 | 1.21 | $41,024 | $26,312 |
| 2017 | 47 | 78 | 77 | 1.23 | $9,417 | $5,842 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 6 services
| Established patient complete exam of visual system | 68 | $7,338 | $94 |
| Return visit (30+ min) | 30 | $3,367 | $109 |
| Imaging of retina | 37 | $1,456 | $34 |
| Established patient problem focused exam of visual system | 13 | $1,277 | $85 |
| Short return visit (20+ min) | 17 | $1,219 | $72 |
| Imaging of optic nerve | 13 | $527 | $33 |
2022: 7 services
| Established patient complete exam of visual system | 88 | $9,804 | $104 |
| Short return visit (20+ min) | 33 | $2,920 | $79 |
| Established patient problem focused exam of visual system | 28 | $2,224 | $67 |
| Imaging of retina | 34 | $1,275 | $35 |
| Exam of visual field with extended testing | 17 | $812 | $43 |
| Imaging of optic nerve | 18 | $525 | $28 |
| Photography of the retina | 16 | $514 | $32 |
2021: 7 services
| Established patient complete exam of visual system | 87 | $11,232 | $107 |
| Established patient problem focused exam of visual system | 57 | $6,391 | $84 |
| New patient visit (45+ min) | 16 | $2,110 | $132 |
| Imaging of retina | 27 | $1,198 | $36 |
| Exam of visual field with extended testing | 11 | $782 | $65 |
| Imaging of optic nerve | 21 | $760 | $33 |
| Photography of the retina | 16 | $621 | $39 |
2020: 6 services
| Established patient complete exam of visual system | 96 | $10,446 | $99 |
| Established patient problem focused exam of visual system | 27 | $2,416 | $78 |
| New patient visit (45+ min) | 15 | $1,561 | $104 |
| Imaging of retina | 29 | $1,082 | $35 |
| Short return visit (20+ min) | 15 | $1,017 | $57 |
| Photography of the retina | 11 | $505 | $46 |
2019: 9 services
| Established patient complete exam of visual system | 90 | $10,506 | $99 |
| Established patient problem focused exam of visual system | 39 | $3,432 | $84 |
| New patient complete exam of visual system | 28 | $2,906 | $104 |
| Short return visit (20+ min) | 42 | $2,819 | $58 |
| Imaging of retina | 24 | $1,088 | $38 |
| Short return visit | 23 | $958 | $38 |
| Exam of visual field with extended testing | 14 | $829 | $55 |
| Photography of the retina | 16 | $764 | $48 |
| Imaging of optic nerve | 14 | $609 | $36 |
2018: 9 services
| Established patient complete exam of visual system | 88 | $10,404 | $108 |
| New patient complete exam of visual system | 36 | $4,312 | $120 |
| Established patient problem focused exam of visual system | 35 | $3,225 | $81 |
| Short return visit (20+ min) | 27 | $1,798 | $60 |
| Photography of the retina | 29 | $1,572 | $54 |
| Imaging of retina | 28 | $1,107 | $38 |
| Exam of visual field with extended testing | 11 | $960 | $64 |
| Short return visit | 20 | $797 | $35 |
| Imaging of optic nerve | 21 | $767 | $35 |
2017: 1 service
| Established patient complete exam of visual system | 20 | $2,192 | $104 |
Medicaid work
$8 in 2023
Medicaid paid $8 for 12 billed services this clinician did in 2023, up to 12 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| DETERMINATION REFRACTIVE STATE | 12 | $8 |
| 2023 | 12 | 1 | 12 | $8 |
| 2020 | 39 | 1 | 14 | $40 |
| 2019 | 27 | 1 | 15 | $24 |
See the largest Medicaid services in earlier years
2020
| DETERMINATION REFRACTIVE STATE | 39 | $40 |
2019
| DETERMINATION REFRACTIVE STATE | 27 | $24 |
Drugs they prescribed that Part D paid
$35,322
Pharmacies billed $35,322 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 115) in 2024. At or below the middle of the specialty; the typical optometry clinician is at 0%.
50 generic and 65 brand-name prescriptions · $35,322 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Latanoprost | 14 | $107 | $4 |
Year by year
| 2024 | 115 | 70 | 0% (0) | 57% | $35,322 |
| 2023 | 113 | 45 | 0% (0) | 78% | $60,384 |
| 2022 | 129 | 45 | 0% (0) | 64% | $67,164 |
| 2021 | 133 | 46 | 0% (0) | 71% | $53,591 |
| 2020 | 153 | 50 | 0% (0) | 70% | $61,862 |
| 2019 | 159 | 49 | 0% (0) | 58% | $45,707 |
| 2018 | 104 | 42 | 0% (0) | 59% | $17,523 |
| 2017 | 99 | 30 | 0% (0) | 57% | $15,722 |
| 2016 | 21 | 15 | 0% (0) | 57% | $2,591 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 3 drugs
| Xiidra | 14 | $29,538 | $2,110 |
| Restasis | 17 | $17,100 | $1,006 |
| Latanoprost | 34 | $1,104 | $32 |
2022: 3 drugs
| Restasis | 21 | $36,794 | $1,752 |
| Latanoprost | 40 | $1,358 | $34 |
| Prednisolone Acetate | 13 | $773 | $59 |
2021: 4 drugs
| Restasis | 18 | $25,277 | $1,404 |
| Travoprost | 11 | $1,459 | $133 |
| Latanoprost | 17 | $632 | $37 |
| Prednisolone Acetate | 15 | $536 | $36 |
2020: 7 drugs
| Restasis | 18 | $26,167 | $1,454 |
| Xiidra | 12 | $12,734 | $1,061 |
| Pazeo | 22 | $5,626 | $256 |
| Combigan | 11 | $4,797 | $436 |
| Latanoprost | 17 | $652 | $38 |
| Prednisolone Acetate | 12 | $616 | $51 |
| Dorzolamide | 13 | $303 | $23 |
2019: 6 drugs
| Restasis | 17 | $18,872 | $1,110 |
| Pazeo | 25 | $5,221 | $209 |
| Travatan Z | 16 | $4,919 | $307 |
| Latanoprost | 27 | $693 | $26 |
| Dorzolamide | 11 | $324 | $29 |
| Erythromycin | 11 | $145 | $13 |
2018: 1 drug
| Latanoprost | 25 | $289 | $12 |
2017: 3 drugs
| Combigan | 14 | $3,256 | $233 |
| Latanoprost | 19 | $231 | $12 |
| Timolol Maleate | 15 | $152 | $10 |
Money from drug and device companies
$303 in 2025
| 2025 | 8 | 10 | None | $303 |
| 2024 | 6 | 10 | None | $332 |
| 2023 | 9 | 20 | None | $678 |
| 2022 | 10 | 24 | None | $569 |
| 2021 | 8 | 19 | None | $717 |
| 2020 | 5 | 7 | None | $173 |
| 2019 | 7 | 11 | None | $245 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Sun Pharmaceutical Industries | Cequa | $82 | 3 payments
|
| Glaukos | Photrexa Viscous and Photrexa | $48 | 1 payment
|
| Johnson & Johnson Surgical Vision | Tecnis Iol | $39 | 1 payment
|
| Oyster Point Pharma | Tyrvaya | $32 | 1 payment
|
| Tarsus Pharmaceuticals | Xdemvy | $31 | 1 payment
|
| Dompe US | Oxervate | $28 | 1 payment
|
See all 10 published payments
| Dompe US | Meals · 2025-11-06 | Oxervate | $28 |
| Johnson & Johnson Surgical Vision | Meals · 2025-09-18 | Tecnis Iol | $39 |
| Sun Pharmaceutical Industries | Meals · 2025-08-21 | Cequa | $24 |
| Glaukos | Meals · 2025-06-10 | Photrexa Viscous and Photrexa | $48 |
| Sun Pharmaceutical Industries | Meals · 2025-05-19 | Cequa | $34 |
| RxSight | Meals · 2025-05-01 | Rxsight Contact Lens | $22 |
| Tarsus Pharmaceuticals | Meals · 2025-04-17 | Xdemvy | $31 |
| Oyster Point Pharma | Meals · 2025-03-07 | Tyrvaya | $32 |
| Sun Pharmaceutical Industries | Meals · 2025-02-04 | Cequa | $24 |
| Abbvie | Meals · 2025-01-21 | Durysta | $20 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $332
| Alcon Vision | Wavelight Refractive Suite | $149 | 2 payments
|
| Oyster Point Pharma | Tyrvaya | $77 | 3 payments
|
| Sun Pharmaceutical Industries | Cequa | $52 | 2 payments
|
| RxSight | Rxsight Contact Lens | $21 | 1 payment
|
| Dompe US | Oxervate | $17 | 1 payment
|
| Johnson & Johnson Surgical Vision | Tecnis Iol | $16 | 1 payment
|
2023: $678
| Oyster Point Pharma | Tyrvaya | $237 | 5 payments
|
| Visionary Optics | None | $135 | 1 payment
|
| Sun Pharmaceutical Industries | Cequa | $107 | 4 payments
|
| Alcon Vision | Rocklatan | $83 | 4 payments
|
| Bausch & Lomb Americas | Miebo | $41 | 2 payments
|
| AbbVie | Lumigan | $22 | 1 payment
|
| Johnson & Johnson Surgical Vision | Tecnis Iol | $20 | 1 payment
|
| Novartis Pharmaceuticals | Xiidra | $19 | 1 payment
|
| Thea Pharma | None | $14 | 1 payment
|
2022: $569
| Oyster Point Pharma | Tyrvaya | $217 | 7 payments
|
| Alcon Vision | Rhopressa | $59 | 3 payments
|
| Novartis Pharmaceuticals | Xiidra | $58 | 3 payments
|
| Kala Pharmaceuticals | Inveltys | $54 | 3 payments
|
| Sun Pharmaceutical Industries | Cequa | $43 | 2 payments
|
| BioTissue Holdings | Prokera | $43 | 1 payment
|
| Bausch & Lomb Americas | Vyzulta | $33 | 2 payments
|
| Johnson & Johnson Surgical Vision | Tecnis Iol | $23 | 1 payment
|
| Allergan | Vuity | $21 | 1 payment
|
| Sight Sciences | Omni(R) Surgical System (US) | $18 | 1 payment
|
2021: $717
| Visionary Optics | None | $365 | 1 payment
|
| Sun Pharmaceutical Industries | Cequa | $119 | 7 payments
|
| Tissuetech | Prokera | $61 | 2 payments
|
| Kala Pharmaceuticals | Inveltys | $47 | 3 payments
|
| Novartis Pharmaceuticals | Xiidra | $45 | 2 payments
|
| Aerie Pharmaceuticals | Rocklatan | $37 | 2 payments
|
| Johnson & Johnson Surgical Vision | Tecnis Iol | $23 | 1 payment
|
| Dompe US | Oxervate | $20 | 1 payment
|
2020: $173
| Sun Pharmaceutical Industries | Cequa | $68 | 3 payments
|
| Alcon Vision | Acrysof Iq Panoptix | $43 | 1 payment
|
| Aerie Pharmaceuticals | Rocklatan | $27 | 1 payment
|
| Novartis Pharmaceuticals | Xiidra | $20 | 1 payment
|
| Johnson & Johnson Vision Care | Acuvue | $17 | 1 payment
|
2019: $245
| Glaukos | Istent Trabecular Micro-Bypass Stent System | $65 | 1 payment
|
| Bausch & Lomb a division of Bausch Health US | Besivance | $53 | 3 payments
|
| Sun Pharmaceutical Industries | Bromsite | $45 | 2 payments
|
| Alcon Vision | Restor | $37 | 2 payments
|
| Shire North American Group | Xiidra | $25 | 1 payment
|
| Eyevance Pharmaceuticals | Flarex | $17 | 1 payment
|
| Johnson & Johnson Surgical Vision | None | $4 | 1 payment
|
Professional record
- NPI
- 1093199606
- Licence
- CA 15281California A15281: Cancelled
- Trained
- University of California - School of Optometry, 2015 · 11 years ago
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 152W00000X (152W00000X)
- Mailing address
- 276 Dolores Ave, San Leandro, CA, 94577
- NPI first listed
- 2015-07-13
- NPI last updated
- 2016-07-22
This is when the NPI record was last certified, not a medical board exam.